Global and United States Monogenetic Disorders Testing Market Report & Forecast 2023-2028

Report ID: 1860653 | Published Date: Sep 2024 | No. of Page: 104 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
1 Study Coverage
    1.1 Monogenetic Disorders Testing Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Monogenetic Disorders Testing Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Monogenetic Disorders Testing Market Size for the Year 2017-2028
        1.2.2 Global Monogenetic Disorders Testing Market Size for the Year 2017-2028
    1.3 Monogenetic Disorders Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Monogenetic Disorders Testing in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Monogenetic Disorders Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Monogenetic Disorders Testing Market Dynamics
        1.4.1 Monogenetic Disorders Testing Industry Trends
        1.4.2 Monogenetic Disorders Testing Market Drivers
        1.4.3 Monogenetic Disorders Testing Market Challenges
        1.4.4 Monogenetic Disorders Testing Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Monogenetic Disorders Testing by Type
    2.1 Monogenetic Disorders Testing Market Segment by Type
        2.1.1 Carrier Testing
        2.1.2 Diagnostic Testing
        2.1.3 New-Born Screening
        2.1.4 Predictive & Pre-Symptomatic Testing
        2.1.5 Prenatal Testing
        2.1.6 Others
    2.2 Global Monogenetic Disorders Testing Market Size by Type (2017, 2022 & 2028)
    2.3 Global Monogenetic Disorders Testing Market Size by Type (2017-2028)
    2.4 United States Monogenetic Disorders Testing Market Size by Type (2017, 2022 & 2028)
    2.5 United States Monogenetic Disorders Testing Market Size by Type (2017-2028)
3 Monogenetic Disorders Testing by Application
    3.1 Monogenetic Disorders Testing Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Specialized Clinics
        3.1.3 Ambulatory Surgical Centers
    3.2 Global Monogenetic Disorders Testing Market Size by Application (2017, 2022 & 2028)
    3.3 Global Monogenetic Disorders Testing Market Size by Application (2017-2028)
    3.4 United States Monogenetic Disorders Testing Market Size by Application (2017, 2022 & 2028)
    3.5 United States Monogenetic Disorders Testing Market Size by Application (2017-2028)
4 Global Monogenetic Disorders Testing Competitor Landscape by Company
    4.1 Global Monogenetic Disorders Testing Market Size by Company
        4.1.1 Top Global Monogenetic Disorders Testing Companies Ranked by Revenue (2021)
        4.1.2 Global Monogenetic Disorders Testing Revenue by Player (2017-2022)
    4.2 Global Monogenetic Disorders Testing Concentration Ratio (CR)
        4.2.1 Monogenetic Disorders Testing Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Monogenetic Disorders Testing in 2021
        4.2.3 Global Monogenetic Disorders Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Monogenetic Disorders Testing Headquarters, Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Monogenetic Disorders Testing Headquarters and Area Served
        4.3.2 Global Monogenetic Disorders Testing Companies Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Monogenetic Disorders Testing Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Monogenetic Disorders Testing Market Size by Company
        4.5.1 Top Monogenetic Disorders Testing Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Monogenetic Disorders Testing Revenue by Players (2020, 2021 & 2022)
5 Global Monogenetic Disorders Testing Market Size by Region
    5.1 Global Monogenetic Disorders Testing Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Monogenetic Disorders Testing Market Size by Region (2017-2028)
        5.2.1 Global Monogenetic Disorders Testing Market Size by Region: 2017-2022
        5.2.2 Global Monogenetic Disorders Testing Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Monogenetic Disorders Testing Market Size YoY Growth 2017-2028
        6.1.2 North America Monogenetic Disorders Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Monogenetic Disorders Testing Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Monogenetic Disorders Testing Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Monogenetic Disorders Testing Market Size YoY Growth 2017-2028
        6.3.2 Europe Monogenetic Disorders Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Monogenetic Disorders Testing Market Size YoY Growth 2017-2028
        6.4.2 Latin America Monogenetic Disorders Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Monogenetic Disorders Testing Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Monogenetic Disorders Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Celera Group
        7.1.1 Celera Group Company Details
        7.1.2 Celera Group Business Overview
        7.1.3 Celera Group Monogenetic Disorders Testing Introduction
        7.1.4 Celera Group Revenue in Monogenetic Disorders Testing Business (2017-2022)
        7.1.5 Celera Group Recent Development
    7.2 Abbott
        7.2.1 Abbott Company Details
        7.2.2 Abbott Business Overview
        7.2.3 Abbott Monogenetic Disorders Testing Introduction
        7.2.4 Abbott Revenue in Monogenetic Disorders Testing Business (2017-2022)
        7.2.5 Abbott Recent Development
    7.3 Thermo Fisher Scientific
        7.3.1 Thermo Fisher Scientific Company Details
        7.3.2 Thermo Fisher Scientific Business Overview
        7.3.3 Thermo Fisher Scientific Monogenetic Disorders Testing Introduction
        7.3.4 Thermo Fisher Scientific Revenue in Monogenetic Disorders Testing Business (2017-2022)
        7.3.5 Thermo Fisher Scientific Recent Development
    7.4 ELITech Group
        7.4.1 ELITech Group Company Details
        7.4.2 ELITech Group Business Overview
        7.4.3 ELITech Group Monogenetic Disorders Testing Introduction
        7.4.4 ELITech Group Revenue in Monogenetic Disorders Testing Business (2017-2022)
        7.4.5 ELITech Group Recent Development
    7.5 Quest
        7.5.1 Quest Company Details
        7.5.2 Quest Business Overview
        7.5.3 Quest Monogenetic Disorders Testing Introduction
        7.5.4 Quest Revenue in Monogenetic Disorders Testing Business (2017-2022)
        7.5.5 Quest Recent Development
    7.6 AutoGenomics
        7.6.1 AutoGenomics Company Details
        7.6.2 AutoGenomics Business Overview
        7.6.3 AutoGenomics Monogenetic Disorders Testing Introduction
        7.6.4 AutoGenomics Revenue in Monogenetic Disorders Testing Business (2017-2022)
        7.6.5 AutoGenomics Recent Development
    7.7 PerkinElmer
        7.7.1 PerkinElmer Company Details
        7.7.2 PerkinElmer Business Overview
        7.7.3 PerkinElmer Monogenetic Disorders Testing Introduction
        7.7.4 PerkinElmer Revenue in Monogenetic Disorders Testing Business (2017-2022)
        7.7.5 PerkinElmer Recent Development
    7.8 Roche
        7.8.1 Roche Company Details
        7.8.2 Roche Business Overview
        7.8.3 Roche Monogenetic Disorders Testing Introduction
        7.8.4 Roche Revenue in Monogenetic Disorders Testing Business (2017-2022)
        7.8.5 Roche Recent Development
    7.9 Bio-Rad
        7.9.1 Bio-Rad Company Details
        7.9.2 Bio-Rad Business Overview
        7.9.3 Bio-Rad Monogenetic Disorders Testing Introduction
        7.9.4 Bio-Rad Revenue in Monogenetic Disorders Testing Business (2017-2022)
        7.9.5 Bio-Rad Recent Development
    7.10 Transgenomic
        7.10.1 Transgenomic Company Details
        7.10.2 Transgenomic Business Overview
        7.10.3 Transgenomic Monogenetic Disorders Testing Introduction
        7.10.4 Transgenomic Revenue in Monogenetic Disorders Testing Business (2017-2022)
        7.10.5 Transgenomic Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. Monogenetic Disorders Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Monogenetic Disorders Testing Market Trends
    Table 3. Monogenetic Disorders Testing Market Drivers
    Table 4. Monogenetic Disorders Testing Market Challenges
    Table 5. Monogenetic Disorders Testing Market Restraints
    Table 6. Global Monogenetic Disorders Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Monogenetic Disorders Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Monogenetic Disorders Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Monogenetic Disorders Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Monogenetic Disorders Testing Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Monogenetic Disorders Testing Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Monogenetic Disorders Testing Revenue Share by Player, 2017-2022
    Table 13. Global Monogenetic Disorders Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Monogenetic Disorders Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenetic Disorders Testing as of 2021)
    Table 15. Top Players of Monogenetic Disorders Testing in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Monogenetic Disorders Testing Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Monogenetic Disorders Testing Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Monogenetic Disorders Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Monogenetic Disorders Testing Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Monogenetic Disorders Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Monogenetic Disorders Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Monogenetic Disorders Testing Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Monogenetic Disorders Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Monogenetic Disorders Testing Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Monogenetic Disorders Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Monogenetic Disorders Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Monogenetic Disorders Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Celera Group Company Details
    Table 31. Celera Group Business Overview
    Table 32. Celera Group Monogenetic Disorders Testing Product
    Table 33. Celera Group Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
    Table 34. Celera Group Recent Development
    Table 35. Abbott Company Details
    Table 36. Abbott Business Overview
    Table 37. Abbott Monogenetic Disorders Testing Product
    Table 38. Abbott Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
    Table 39. Abbott Recent Development
    Table 40. Thermo Fisher Scientific Company Details
    Table 41. Thermo Fisher Scientific Business Overview
    Table 42. Thermo Fisher Scientific Monogenetic Disorders Testing Product
    Table 43. Thermo Fisher Scientific Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
    Table 44. Thermo Fisher Scientific Recent Development
    Table 45. ELITech Group Company Details
    Table 46. ELITech Group Business Overview
    Table 47. ELITech Group Monogenetic Disorders Testing Product
    Table 48. ELITech Group Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
    Table 49. ELITech Group Recent Development
    Table 50. Quest Company Details
    Table 51. Quest Business Overview
    Table 52. Quest Monogenetic Disorders Testing Product
    Table 53. Quest Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
    Table 54. Quest Recent Development
    Table 55. AutoGenomics Company Details
    Table 56. AutoGenomics Business Overview
    Table 57. AutoGenomics Monogenetic Disorders Testing Product
    Table 58. AutoGenomics Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
    Table 59. AutoGenomics Recent Development
    Table 60. PerkinElmer Company Details
    Table 61. PerkinElmer Business Overview
    Table 62. PerkinElmer Monogenetic Disorders Testing Product
    Table 63. PerkinElmer Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
    Table 64. PerkinElmer Recent Development
    Table 65. Roche Company Details
    Table 66. Roche Business Overview
    Table 67. Roche Monogenetic Disorders Testing Product
    Table 68. Roche Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
    Table 69. Roche Recent Development
    Table 70. Bio-Rad Company Details
    Table 71. Bio-Rad Business Overview
    Table 72. Bio-Rad Monogenetic Disorders Testing Product
    Table 73. Bio-Rad Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
    Table 74. Bio-Rad Recent Development
    Table 75. Transgenomic Company Details
    Table 76. Transgenomic Business Overview
    Table 77. Transgenomic Monogenetic Disorders Testing Product
    Table 78. Transgenomic Revenue in Monogenetic Disorders Testing Business (2017-2022) & (US$ Million)
    Table 79. Transgenomic Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Monogenetic Disorders Testing Product Picture
    Figure 2. Global Monogenetic Disorders Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Monogenetic Disorders Testing Market Size 2017-2028 (US$ Million)
    Figure 4. United States Monogenetic Disorders Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Monogenetic Disorders Testing Market Size 2017-2028 (US$ Million)
    Figure 6. United States Monogenetic Disorders Testing Market Share in Global 2017-2028
    Figure 7. Monogenetic Disorders Testing Report Years Considered
    Figure 8. Product Picture of Carrier Testing
    Figure 9. Product Picture of Diagnostic Testing
    Figure 10. Product Picture of New-Born Screening
    Figure 11. Product Picture of Predictive & Pre-Symptomatic Testing
    Figure 12. Product Picture of Prenatal Testing
    Figure 13. Product Picture of Others
    Figure 14. Global Monogenetic Disorders Testing Market Share by Type in 2022 & 2028
    Figure 15. Global Monogenetic Disorders Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Monogenetic Disorders Testing Market Share by Type (2017-2028)
    Figure 17. United States Monogenetic Disorders Testing Market Share by Type in 2022 & 2028
    Figure 18. United States Monogenetic Disorders Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Monogenetic Disorders Testing Market Share by Type (2017-2028)
    Figure 20. Product Picture of Hospitals
    Figure 21. Product Picture of Specialized Clinics
    Figure 22. Product Picture of Ambulatory Surgical Centers
    Figure 23. Global Monogenetic Disorders Testing Market Share by Application in 2022 & 2028
    Figure 24. Global Monogenetic Disorders Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Monogenetic Disorders Testing Market Share by Application (2017-2028)
    Figure 26. United States Monogenetic Disorders Testing Market Share by Application in 2022 & 2028
    Figure 27. United States Monogenetic Disorders Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Monogenetic Disorders Testing Market Share by Application (2017-2028)
    Figure 29. North America Monogenetic Disorders Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Monogenetic Disorders Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Monogenetic Disorders Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Monogenetic Disorders Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Monogenetic Disorders Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. UAE Monogenetic Disorders Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Celera Group Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
    Figure 58. Abbott Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
    Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
    Figure 60. ELITech Group Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
    Figure 61. Quest Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
    Figure 62. AutoGenomics Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
    Figure 63. PerkinElmer Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
    Figure 64. Roche Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
    Figure 65. Bio-Rad Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
    Figure 66. Transgenomic Revenue Growth Rate in Monogenetic Disorders Testing Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Celera Group
Abbott
Thermo Fisher Scientific
ELITech Group
Quest
AutoGenomics
PerkinElmer
Roche
Bio-Rad
Transgenomic
Frequently Asked Questions
Monogenetic Disorders Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Monogenetic Disorders Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Monogenetic Disorders Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Morel Mushroom

Morel Mushroom market is segmented by region (country), players, by Type and by Application. Play ... Read More